• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性肝肿瘤不可逆电穿孔治疗后 1 年内钆塞酸增强磁共振成像的变化。

Changes in gadoxetic-acid-enhanced MR imaging during the first year after irreversible electroporation of malignant hepatic tumors.

机构信息

Department of Radiology, University Hospital Regensburg, Regensburg, Germany.

Department of Radiology and Nuclear Medicine, Hospital Braunschweig, Braunschweig, Germany.

出版信息

PLoS One. 2020 Nov 17;15(11):e0242093. doi: 10.1371/journal.pone.0242093. eCollection 2020.

DOI:10.1371/journal.pone.0242093
PMID:33201902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7671553/
Abstract

PURPOSE

To evaluate the appearance and size of ablation zones in gadoxetic-acid-enhanced magnetic resonance imaging (MRI) during the first year after irreversible electroporation (IRE) of primary or secondary hepatic malignancies and to investigate potential correlations to clinical features.

MATERIAL AND METHODS

The MRI-appearance of the ablation area was assessed 1-3 days, 6 weeks, 3 months, 6 months, 9 months and 1 year after IRE. The size of the ablation zone and signal intensities of each follow-up control were compared. Moreover, relationships between clinical features and the MRI-appearance of the ablation area 1-3 days after IRE were analyzed.

RESULTS

The ablation zone size decreased from 5.6 ± 1.4 cm (1-3 days) to 3.7±1.2 cm (1 year). A significant decrease of central hypointensities was observed in T2-blade- (3 months), T2 haste- (6 weeks; 3 months; 6 months; 1 year), T1 arterial phase- (3 months; 1 year), and diffusion-sequences (6 weeks; 3 months; 6 months; 9 months; 1 year). The unenhanced T1-sequences showed significantly increasing central hypointensities (6 weeks; 3 months; 6 months; 9 months; 1 year). Significantly increasing peripheral hypointensities were detected in T1 arterial phase- (3 months; 6 months; 9 months; 1 year) and in T1 portal venous phase-sequences (6 weeks; 3 months; 6 months; 9 months; 1 year). Peripheral hypointensities of unenhanced T1-sequences decreased significantly 1 year after IRE. 1-3 days after IRE central T1 portal venous hypo- or isointensities were detected significantly more often than hyperintensities, if more than 3 IRE electrodes were used.

CONCLUSION

Hepatic IRE results in continuous reduction of ablation zone size during the first postinterventional year. In addition to centrally decreasing T1-signal and almost steadily increasing signal in the enhanced T2 haste-, diffusion- and T1 arterial phase-sequences, there is a trend toward long-term decreasing T1 arterial- and portal venous MRI-signal intensity of the peripheral ablation area, probably representing a region of reversible electroporation.

摘要

目的

在原发性或继发性肝恶性肿瘤不可逆电穿孔(IRE)后 1 年内,评估钆塞酸增强磁共振成像(MRI)中消融区的外观和大小,并探讨其与临床特征的潜在相关性。

材料与方法

IRE 后 1-3 天、6 周、3 个月、6 个月、9 个月和 1 年,评估消融区的 MRI 外观。比较每个随访控制的消融区大小和信号强度。此外,分析了 IRE 后 1-3 天与消融区 MRI 外观相关的临床特征。

结果

消融区大小从 5.6±1.4cm(1-3 天)减少到 3.7±1.2cm(1 年)。在 T2 叶片(3 个月)、T2 haste(6 周;3 个月;6 个月;1 年)、T1 动脉期(3 个月;1 年)和弥散序列(6 周;3 个月;6 个月;9 个月;1 年)中观察到中央低信号显著减少。未增强 T1 序列显示中央低信号显著增加(6 周;3 个月;6 个月;9 个月;1 年)。在 T1 动脉期(3 个月;6 个月;9 个月;1 年)和 T1 门静脉期序列(6 周;3 个月;6 个月;9 个月;1 年)中检测到明显增加的外周低信号。IRE 后 1 年,未增强 T1 序列的外周低信号显著减少。IRE 后 1-3 天,如果使用超过 3 个 IRE 电极,则检测到中央 T1 门静脉低信号或等信号明显多于高信号。

结论

在首次介入后 1 年内,IRE 导致消融区大小持续减少。除了中央 T1 信号逐渐降低,增强 T2 haste、弥散和 T1 动脉期序列中的信号几乎稳定增加外,外周消融区 T1 动脉期和门静脉 MRI 信号强度也呈长期下降趋势,可能代表可逆电穿孔区域。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a3/7671553/1fdc6e8ec650/pone.0242093.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a3/7671553/515af195894a/pone.0242093.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a3/7671553/75044c93bcd2/pone.0242093.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a3/7671553/46e1f68cf589/pone.0242093.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a3/7671553/1fdc6e8ec650/pone.0242093.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a3/7671553/515af195894a/pone.0242093.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a3/7671553/75044c93bcd2/pone.0242093.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a3/7671553/46e1f68cf589/pone.0242093.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a3/7671553/1fdc6e8ec650/pone.0242093.g004.jpg

相似文献

1
Changes in gadoxetic-acid-enhanced MR imaging during the first year after irreversible electroporation of malignant hepatic tumors.恶性肝肿瘤不可逆电穿孔治疗后 1 年内钆塞酸增强磁共振成像的变化。
PLoS One. 2020 Nov 17;15(11):e0242093. doi: 10.1371/journal.pone.0242093. eCollection 2020.
2
Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.肝细胞癌不可逆电穿孔:磁共振成像、计算机断层扫描及超声造影在评估消融区域诊断准确性的初步报告
Radiol Med. 2016 Feb;121(2):122-31. doi: 10.1007/s11547-015-0582-5. Epub 2015 Sep 7.
3
Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.恶性肝肿瘤的不可逆电穿孔——亚急性随访时静脉结构的改变及中期随访时的演变
PLoS One. 2015 Aug 13;10(8):e0135773. doi: 10.1371/journal.pone.0135773. eCollection 2015.
4
Magnetic Resonance Imaging Findings After Percutaneous Irreversible Electroporation of Liver Metastases: A Systematic Longitudinal Study.经皮不可逆电穿孔治疗肝转移瘤后的磁共振成像结果:一项系统性纵向研究
Invest Radiol. 2017 Jan;52(1):23-29. doi: 10.1097/RLI.0000000000000301.
5
Irreversible electroporation in the liver: contrast-enhanced inversion-recovery MR imaging approaches to differentiate reversibly electroporated penumbra from irreversibly electroporated ablation zones.肝脏中的不可逆电穿孔:采用对比增强反转恢复磁共振成像方法区分可逆电穿孔半暗带与不可逆电穿孔消融区。
Radiology. 2011 Feb;258(2):461-8. doi: 10.1148/radiol.10100645. Epub 2010 Dec 3.
6
Irreversible Electroporation in Patients with Hepatocellular Carcinoma: Immediate versus Delayed Findings at MR Imaging.不可逆电穿孔治疗肝细胞癌患者:MR 成像的即刻与延迟表现。
Radiology. 2016 Jan;278(1):285-94. doi: 10.1148/radiol.2015150031. Epub 2015 Nov 2.
7
Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins.肝脏靠近大血管恶性肿瘤的不可逆电穿孔术的中期安全性和有效性。
Radiology. 2017 Dec;285(3):1023-1031. doi: 10.1148/radiol.2017161561. Epub 2017 Aug 11.
8
Comparison of Chronologic Change in the Size and Contrast-Enhancement of Ablation Zones on CT Images after Irreversible Electroporation and Radiofrequency Ablation.不可逆电穿孔与射频消融术后 CT 图像上消融区域大小和增强程度的时相变化比较。
Korean J Radiol. 2018 Jul-Aug;19(4):560-567. doi: 10.3348/kjr.2018.19.4.560. Epub 2018 Jun 14.
9
Irreversible electroporation ablation of malignant hepatic tumors: subacute and follow-up CT appearance of ablation zones.恶性肝肿瘤的不可逆电穿孔消融:消融区的亚急性及随访CT表现
J Vasc Interv Radiol. 2014 Oct;25(10):1589-94. doi: 10.1016/j.jvir.2014.06.026. Epub 2014 Aug 23.
10
Irreversible Electroporation: Defining the MRI Appearance of the Ablation Zone With Histopathologic Correlation in a Porcine Liver Model.不可逆电穿孔:在猪肝脏模型中通过组织病理学相关性定义消融区的MRI表现
AJR Am J Roentgenol. 2017 May;208(5):1141-1146. doi: 10.2214/AJR.16.17207. Epub 2017 Feb 8.

本文引用的文献

1
Irreversible Electroporation: Defining the MRI Appearance of the Ablation Zone With Histopathologic Correlation in a Porcine Liver Model.不可逆电穿孔:在猪肝脏模型中通过组织病理学相关性定义消融区的MRI表现
AJR Am J Roentgenol. 2017 May;208(5):1141-1146. doi: 10.2214/AJR.16.17207. Epub 2017 Feb 8.
2
Magnetic Resonance Imaging Findings After Percutaneous Irreversible Electroporation of Liver Metastases: A Systematic Longitudinal Study.经皮不可逆电穿孔治疗肝转移瘤后的磁共振成像结果:一项系统性纵向研究
Invest Radiol. 2017 Jan;52(1):23-29. doi: 10.1097/RLI.0000000000000301.
3
Irreversible Electroporation in Patients with Hepatocellular Carcinoma: Immediate versus Delayed Findings at MR Imaging.
不可逆电穿孔治疗肝细胞癌患者:MR 成像的即刻与延迟表现。
Radiology. 2016 Jan;278(1):285-94. doi: 10.1148/radiol.2015150031. Epub 2015 Nov 2.
4
Percutaneous ablation therapy of hepatocellular carcinoma with irreversible electroporation: MRI findings.经皮不可逆电穿孔消融治疗肝细胞癌的 MRI 表现。
AJR Am J Roentgenol. 2015 May;204(5):1000-7. doi: 10.2214/AJR.14.12509.
5
Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update: supplement to the consensus document.影像引导下肿瘤消融:术语和报告标准的标准化——十年更新:共识文件补充版
J Vasc Interv Radiol. 2014 Nov;25(11):1706-8. doi: 10.1016/j.jvir.2014.09.005. Epub 2014 Oct 23.
6
Percutaneous irreversible electroporation for the treatment of colorectal cancer liver metastases with a proposal for a new response evaluation system.经皮不可逆电穿孔治疗结直肠癌肝转移并提出一种新的疗效评估系统
J Vasc Interv Radiol. 2014 Aug;25(8):1233-1239.e2. doi: 10.1016/j.jvir.2014.04.007. Epub 2014 May 24.
7
Perivascular versus nonperivascular small HCC treated with percutaneous RF ablation: retrospective comparison of long-term therapeutic outcomes.经皮射频消融治疗血管周围与非血管周围小 HCC:长期疗效的回顾性比较。
Radiology. 2014 Mar;270(3):888-99. doi: 10.1148/radiol.13130753. Epub 2013 Nov 22.
8
Irreversible electroporation ablation (IRE) of unresectable soft tissue tumors: learning curve evaluation in the first 150 patients treated.不可逆转电穿孔消融(IRE)治疗不可切除的软组织肿瘤:150 例患者的学习曲线评估。
PLoS One. 2013 Nov 1;8(11):e76260. doi: 10.1371/journal.pone.0076260. eCollection 2013.
9
Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures.毗邻重要结构的肝脏肿瘤采用不可逆电穿孔治疗的安全性和早期疗效。
J Surg Oncol. 2013 Apr;107(5):544-9. doi: 10.1002/jso.23280. Epub 2012 Oct 22.
10
Ablation of perivascular hepatic malignant tumors with irreversible electroporation.不可逆电穿孔消融治疗肝血管周围恶性肿瘤。
J Am Coll Surg. 2012 Sep;215(3):379-87. doi: 10.1016/j.jamcollsurg.2012.04.029. Epub 2012 Jun 16.